FDA Updates Ozempic Label with Intestinal Blockage Warning

The weight loss drug Ozempic has taken the world by storm, but using a drug developed for diabetes for weight control is proving to have unexpected consequences. According to a recent diaTribe Learn article, the FDA has issued a warning for the drug due to reports of intestinal blockages (ileus) associated with its use. Ileus is a severe gastrointestinal condition where the intestines fail to contract and move waste properly, and about 20 cases, including two deaths, have been linked to Ozempic use. The FDA added a warning to the drug's label, although a direct causal link between Ozempic and ileus has not been established.